Gregory B. Lawless
Corporate Officer/Principal en Collins Mabry & Co. LLC .
Perfil
Gregory B.
Lawless has been Managing Partner of Collins Mabry & Co. since 1998.
Previously, he was President and Chief Executive Officer of Cygnus, Inc. from 1992 to 1998 and President and Chief Operating Officer of Chiron Corporation from 1989 to 1992.
Dr. Lawless received a BS degree in Pharmacy from Fordham University, an MS degree in Analytical Chemistry from St. John's University and a PhD in Physical Organic Chemistry from Temple University.
Cargos activos de Gregory B. Lawless
| Empresas | Cargo | Inicio |
|---|---|---|
| Collins Mabry & Co. LLC | Corporate Officer/Principal | 01/01/1998 |
Antiguos cargos conocidos de Gregory B. Lawless.
| Empresas | Cargo | Fin |
|---|---|---|
Vyteris, Inc.
 Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Director/Miembro de la Junta | 06/02/2008 |
| ORASURE TECHNOLOGIES, INC. | Director/Miembro de la Junta | 16/05/2005 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
| Collins Mabry & Co. LLC |
- Bolsa de valores
- Insiders
- Gregory B. Lawless
